Medimmune

Biologic R&D for oncology; respiratory, inflammation and autoimmune; and cardiovascular and metabolic diseases

placeGaithersburg, Maryland, United States calendar_todayFounded 1987 groups3,000 employees language medimmune.com

Innovation

944 patent families (439 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Operations & transport; filing pace slowing. Cited 154,997 times.

YearFilings
2015213
2016219
2017263
2018229
2019217
2020202
2021189
2022172
2023153
2024140
2025135
202638

Investor mix

7 investors on record.

Investor typeCountShare
Venture capital343%
Private equity229%
Other / undisclosed229%
Coming soon